Clinical Trials Logo
  1. Home
  2. Spondyloarthritis
  3. NCT01029847

Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis — ASIM  

Spondyloarthritis Clinical Trial

Official title:
Adalimumab in Axial Spondyloarthritis. An Investigation of Whole-body MRI, MRI of Sacroiliac Joints and Spine and Soluble Biomarkers of Joint Inflammation and Damage.

Clinical Trial Summary

Investigation of wholebody MRI and circulating biomarkers of inflammation, cartilage and bone metabolism in patients with spondyloarthritis treated with adalimumab. Furthermore to compare ultrasound examination with wholebody MRI etc.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01029847
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase Phase 4
Start date December 2009
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT03564743 - Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
Completed NCT01219257 - Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
Recruiting NCT05433168 - Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis N/A
Terminated NCT03232580 - 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis Phase 2
Recruiting NCT05039216 - Biobank for Inflammatory Chronic Diseases and Osteoporosis
Completed NCT04483648 - Cervical Stabilization Exercises in Patients With Spondyloarthritis N/A
Recruiting NCT04602091 - Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Not yet recruiting NCT04077957 - Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs Phase 4
Recruiting NCT05290363 - The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis N/A
Not yet recruiting NCT05006690 - Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis N/A
Completed NCT02998398 - Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
Completed NCT02148640 - The NOR-SWITCH Study Phase 4
Completed NCT01174186 - Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Phase 4
Recruiting NCT04499001 - Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
Completed NCT03253796 - Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Phase 4
Active, not recruiting NCT04169373 - A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis Phase 3
Recruiting NCT04292067 - Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Completed NCT04946539 - Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
Recruiting NCT03983473 - Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. N/A
Terminated NCT03345355 - MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis